Treatment of Lambert-Eaton Syndrome With 3,4 DAP - Contacts and Locations

Home

Treatment of Lambert-Eaton Syndrome With 3,4 DAP

Expanded access is currently available for this treatment.

Study NCT00704925. Last updated on June 23, 2008. Information provided by University of California, Davis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00704925

Contacts


Contact: Janelle Butters, RN	916-734-6276	janelle.butters@ucdmc.ucdavis.edu

Locations


United States, California
	University of California, Davis
	Sacramento, California, United States, 95827

Sponsors and Collaborators

University of California, Davis

Jacobus Pharmaceutical

Investigators


Principal Investigator:	David Richman, MD	University of California, Davis